T cells with high expression of PD-1 inhibit T cell activity through the PD-1/programmed death ligand 1 (PD-L1) pathway, thereby inhibiting the ability of T cells to kill tumor cells in the tumor microenvironment and allowing the immune escape of tumors43. Here, CD274 is linked to neoplasm.